Stefano Greggi - Publications

Endometrioid borderline ovarian tumour: A multicentre analysis from the MITO-14 study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: January 13, 2025

Hyperthermic Intraperitoneal Chemotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Randomized Trial on Survival Evaluation (HORSE; MITO-18).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 21, 2024

Reply to B. Mutlu Sütcüoğlu et al.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 06, 2024

Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 01, 2023

Outcomes of High-Grade Cervical Dysplasia with Positive Margins and HPV Persistence after Cervical Conization.

Journal: Vaccines

Published: December 30, 2022

Corrigendum to "Assessing the role of minimally invasive radical hysterectomy for early-stage cervical cancer" [Eur. J. Obstet. Gynecol. 275 (2022) 64-69].

Journal: European journal of obstetrics, gynecology, and reproductive biology

Published: September 17, 2022

Radiological assessment of peritoneal carcinomatosis: a primer for resident.

Journal: European review for medical and pharmacological sciences

Published: May 03, 2022

Assessing the role of minimally invasive radical hysterectomy for early-stage cervical cancer.

Journal: European journal of obstetrics, gynecology, and reproductive biology

Published: April 08, 2022

Olaparib beyond progression compared with platinum chemotherapy after secondary cytoreductive surgery in patients with recurrent ovarian cancer: phase III randomized, open-label MITO 35b study, a project of the MITO-MANGO groups.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: March 23, 2022

Development of a Nomogram Predicting the Risk of Persistence/Recurrence of Cervical Dysplasia.

Journal: Vaccines

Published: March 12, 2022

Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22).

Journal: British journal of cancer

Published: February 09, 2022

Fertility-sparing treatment for serous borderline ovarian tumors with extra-ovarian invasive implants: Analysis from the MITO14 study database.

Journal: Gynecologic oncology

Published: January 22, 2022